|
|
Effects of Parathyroidectomy Combined with Forearm Autograft on Biochemical Indexes and Quality of Life in SHPT Patients Undergoing MHD |
ZHANG Wen-Rui, PANG Yi |
Department of General Surgery,Baoji Central Hospital,Baoji Shaanxi 721000 |
|
|
Abstract 【Objective】 To investigate the effect of parathyroidectomy combined with forearm autotransplantation on biochemical indexes and quality of life in patients with maintenance hemodialysis (MHD) and secondary hyperparathyroidism (SHPT). 【Methods】 A total of 96 patients with MHD and SHPT were randomly divided into two groups with 48 cases in each group. The control group underwent simple total parathyroidectomy, and the observation group combined with forearm autograft on the basis of the control group. The levels of blood phosphorus (P3-), blood calcium ( Ca2+), parathyroid hormone (iPTH) and hemoglobin (Hb), quality of life and adverse reactions were compared between the two groups before and 3 months after operation.【Results 】 Three months after operation, the levels of P3-, Ca2+ and iPTH in the two groups were lower than those before operation, and the level of Hb was higher than that before operation (P<0.05); The levels of P3-, Ca2+ and iPTH in the observation group were lower than those in the control group, and the level of Hb was higher than those in the control group (P<0.05). Three months after operation, the scores of overall health, physical pain, social function and body vitality in the two groups were higher than those before operation (P<0.05), and those in the observation group were higher than those in the control group (P<0.05). Three months after operation, the incidence of hoarseness, muscle weakness and recurrent laryngeal nerve injury in the observation group were lower than those in the control group (P<0.05). 【Conclusion】 Parathyroidectomy combined with forearm autograft in the treatment of MHD patients with SHPT can more effectively improve the clinical symptoms, improve the quality of life with high safety.
|
Received: 20 January 2021
|
|
|
|
|
[1] 陈湘华,杨京新,莫健卿.尿毒症维持性血液透析并继发性甲状旁腺功能亢进患者心率变异性的临床研究[J].云南医药2020,41(5):435-437. [2] 贾晓蒙,胡晓东,吕朝晖.难治性甲状腺功能亢进的临床诊治[J].中国实用内科杂志,2019,39(4):316-320. [3] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会.慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J].中国实用外科杂志,2016,36(5):4481-4486. [4] 李春波,何燕玲.健康状况调查问卷SF-36的介绍[J].国外医学:精神病学分册,2002,29(2):116-119. [5] 童昌军,刘勇,周加军,等.甲状旁腺切除联合前臂自体移植术对维持性血液透析患者Klotho/FGF23的影响[J].医学临床研究,2020,37(10):1494-1496. [6] 鲁瑶,孙小亮,张凌.继发性甲状旁腺功能亢进的手术指征与治疗难点[J].临床外科杂志,2020,28(3):19-21. [7] 杨军,曾建,孙红亮.维持性血液透析患者血清钙磷及PTH水平与心脏结构功能的相关性[J].中国临床研究,2019,32(4):527-530. [8] 王绍勇,谭忠麒,袁锋.甲状旁腺全切除术联合自体移植术治疗尿毒症所致继发性甲状旁腺功能亢进症的效果[J].当代医药论丛,2019,17(9):117-119. [9] 周海洋,殷胜强,冉亮,等.合并恶性肿瘤的终末期肾病维持性血液透析患者临床特征及预后分析[J].肿瘤预防与治疗,2020,33(6):481-486. |
[1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(5): 771-773. |
|
|
|
|